ENTA
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- AbbVie partner Enanta announced European Commission approval of MAVIRET for acute hepatitis C infectionJun 23, 2026
- Enanta Pharmaceuticals advanced the clinical development program of zelicapavir for respiratory syncytial virusJun 18, 2026
- Enanta dosed the first participant in Phase 1 trial of EDP-978 for urticariaApr 13, 2026
- Enanta Pharmaceuticals to present data for Zelicapavir and EDP-323, two candidates in development for the treatment of respiratory syncytial virus (RSV) at IDWeek™ 2025Oct 7, 2025
- Enanta Pharmaceuticals reports positive topline results from Phase 2b study of Zelicapavir for treatment of respiratory syncytial virus (RSV) in high-risk adultsSep 29, 2025